DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,053 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,811,312 | +30.6% | 11,252 | +30.6% | 0.57% | +21.4% |
Q1 2024 | $2,151,837 | -9.5% | 8,617 | -16.2% | 0.47% | -9.4% |
Q4 2023 | $2,378,175 | +11.4% | 10,280 | +19.5% | 0.52% | +1.4% |
Q3 2023 | $2,134,156 | +14.2% | 8,602 | +10.5% | 0.51% | +13.2% |
Q2 2023 | $1,869,120 | +28.6% | 7,788 | +34.0% | 0.45% | +18.5% |
Q1 2023 | $1,453,523 | +7.9% | 5,812 | +14.5% | 0.38% | -8.4% |
Q4 2022 | $1,347,272 | +20.1% | 5,076 | +25.8% | 0.42% | +19.8% |
Q3 2022 | $1,122,000 | +36.7% | 4,034 | +24.5% | 0.35% | +37.4% |
Q2 2022 | $821,000 | -13.2% | 3,240 | +0.5% | 0.25% | +6.7% |
Q1 2022 | $946,000 | -10.8% | 3,225 | 0.0% | 0.24% | -1.7% |
Q4 2021 | $1,061,000 | +11.2% | 3,225 | +2.9% | 0.24% | +4.3% |
Q3 2021 | $954,000 | -6.1% | 3,135 | -17.2% | 0.23% | -3.7% |
Q2 2021 | $1,016,000 | +19.2% | 3,785 | 0.0% | 0.24% | +7.6% |
Q1 2021 | $852,000 | +48.7% | 3,785 | +46.8% | 0.22% | +23.8% |
Q4 2020 | $573,000 | +48.4% | 2,578 | +43.8% | 0.18% | +29.3% |
Q3 2020 | $386,000 | +47.3% | 1,793 | +21.1% | 0.14% | +42.9% |
Q2 2020 | $262,000 | -40.2% | 1,480 | -48.3% | 0.10% | +19.5% |
Q4 2019 | $438,000 | +111.6% | 2,860 | +100.0% | 0.08% | -11.8% |
Q3 2019 | $207,000 | +1.5% | 1,430 | 0.0% | 0.09% | 0.0% |
Q2 2019 | $204,000 | – | 1,430 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |